Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 33.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 91,239 shares of the company’s stock after selling 45,684 shares during the quarter. Kornitzer Capital Management Inc. KS’s holdings in Roche were worth $3,215,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Bard Financial Services Inc. increased its position in Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the last quarter. Diversified Trust Co increased its position in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the last quarter. Hantz Financial Services Inc. increased its position in Roche by 0.9% during the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after purchasing an additional 305 shares during the last quarter. Confluence Investment Management LLC increased its position in Roche by 26.3% during the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after purchasing an additional 2,910 shares during the last quarter. Finally, Verity Asset Management Inc. increased its position in Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock worth $280,000 after purchasing an additional 1,697 shares during the last quarter.

Analyst Ratings Changes

Several brokerages recently commented on RHHBY. Morgan Stanley started coverage on shares of Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating for the company. Sanford C. Bernstein raised shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold”.

Roche Stock Performance

Roche stock opened at $40.85 on Wednesday. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43. The firm has a fifty day moving average of $37.24 and a 200-day moving average of $38.31. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.